Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1989
04/11/1989US4820731 Parenteral dietary supplement and method of minimizing effects of infection through diet
04/11/1989US4820724 Dual phase solvent carrier system
04/11/1989US4820716 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
04/11/1989US4820701 Penam derivatives
04/11/1989US4820698 Tetraalkyl ethenylidenebisphosphonates
04/11/1989US4820694 Antibiotics
04/11/1989CA1252404A1 Polyether antibiotics x-14889 a, c and d
04/06/1989WO1989002922A1 Adheson variants
04/06/1989WO1989002918A1 Process for selectively modulating the expression and function of a cell-surface determinant and production of novel human cells produced thereby
04/06/1989WO1989002897A1 Therapeutic peptides
04/06/1989WO1989002746A1 Uses of recombinant colony stimulating factor-1
04/06/1989WO1989002736A1 Siderophores as antiparasitic agents
04/06/1989WO1989002735A1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
04/06/1989WO1989002733A1 Liposomal nucleoside analogues for treating aids
04/06/1989WO1989001933A3 4-quinoline-3-carboxylic acid derivatives and their use as antibacterial agents
04/05/1989EP0310476A1 Inhibitory or destructible composition of at least one unicellular living being containing fluor F- and lithium li+
04/05/1989EP0310362A2 Vaccine for protection of cats against feline infectious peritonitis
04/05/1989EP0310317A2 Inactivation of viruses and bacteria
04/05/1989EP0310316A2 TGEV-virus of swine as a dog vaccine
04/05/1989EP0310214A2 7-Substituted bicyclic pyrazolidinones
04/05/1989EP0310122A1 Antifungal composition
04/05/1989EP0310061A1 5-Mono or Disubstituted-3-(phenyl or 2-naphthalenyl)-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2-(methyl or benzyl)isoxazolidines
04/05/1989EP0309953A1 5-Substituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-isoxazolidines
04/05/1989EP0309952A2 Anti-retroviral castanospermine esters
04/05/1989EP0309789A1 4-Oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
04/05/1989EP0309533A1 Butyl hydroxyanisoles for the treatment of retroviral diseases.
04/05/1989EP0309491A1 Antiviral agents
04/05/1989EP0309477A1 Ecteinascidins 729, 743, 745, 759a, 759b and 770.
04/05/1989EP0165289B1 Novel derivatives of guanine
04/04/1989US4818752 Soluble phosphorylated glucan: methods and compositions for treatment of neoplastic diseases
03/1989
03/29/1989EP0309411A2 Saccharide derivatives
03/29/1989EP0309297A2 Therapeutic peptides
03/29/1989EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells
03/29/1989EP0308783A2 Antimycotic preparations
03/29/1989EP0308782A2 Antimycotic preparations
03/29/1989EP0308781A2 Antimycotic preparations
03/29/1989EP0308424A1 A novel protein, neuroleukin
03/29/1989EP0308416A1 N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
03/29/1989EP0178980B1 Cephalosporin derivatives, process for their preparation and their antibiotic application
03/28/1989US4816582 Bactericides, antibiotics
03/28/1989US4816560 Storage stability
03/28/1989US4816559 Biologically active peptides TAN-866
03/28/1989US4816485 N-phenylbenzamide derivatives
03/28/1989US4816467 Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
03/28/1989US4816451 Antibacterial 1,8-bridged 4-quinolonecarboxylic acids
03/28/1989US4816447 Herpes virus
03/28/1989CA1251785A1 Cephalosporin hydroxamic acids
03/28/1989CA1251747A1 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same
03/23/1989WO1989002438A1 3'-deoxyarabinofuranosylpyrimidine nucleoside derivatives
03/23/1989WO1989002275A1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
03/22/1989EP0308328A1 (Benzyl-piperidino)-1-propanol-2 derivatives, their preparation, their use as microbicides and compositions containing them
03/22/1989EP0308066A2 Promotion of host defense by systemic dsRNA treatment
03/22/1989EP0308065A2 Therapeutic nucleosides
03/22/1989EP0308020A2 5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
03/22/1989EP0308019A2 4-Oxo-4H-quinolizine-3-carboxylic acids and derivatives thereof for treating bacterial infections
03/22/1989EP0307976A1 Mycoplasma vaccine
03/22/1989EP0307914A2 Pharmaceutical compositions containing a dideoxynucleoside
03/22/1989EP0307804A2 Cephem compound and a process for preparation thereof
03/22/1989EP0307599A1 Medicaments for the region of the buccal cavity
03/22/1989CN1031797A Pharmaceutical composition
03/21/1989US4814470 Taxol derivatives, their preparation and pharmaceutical compositions containing them
03/21/1989US4814442 6-hydroxyethyl-2-substituted thio-penem-3-carboxylates
03/21/1989US4814335 Antiviral compounds
03/21/1989US4814332 Antimicrobial 1,3-disubstituted/imidazolium salts
03/21/1989US4814328 Cephalosporin derivatives, and antibacterial agents
03/21/1989CA1251451A1 Benzoseleno¬4,3,2-cd|indazole compositions and methods for their production and use
03/21/1989CA1251450A1 Benzopyrano¬4,3,2-cd|indazole compositions and methods for their production and use
03/21/1989CA1251443A1 Process for preparing 1-dethia 2-thia cephalosporanic acid derivatives
03/21/1989CA1251397A1 Live purified marek's disease vaccine
03/16/1989DE3830123A1 Glasmikrokugeln mit bakteriostatischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendung Glass microspheres having bacteriostatic properties, process for their preparation and their use
03/15/1989EP0307279A2 Use of (5-amino-2-(4-methyl-1-piperidinyl)phenyl)-(4-chlorophenyl)methanone as an antiviral agent
03/15/1989EP0307224A2 Macrolide compounds
03/15/1989EP0307223A2 Process for the preparation of macrolide compounds
03/15/1989EP0307221A2 Process for the preparation of macrolide compounds
03/15/1989EP0307177A2 Erythromycin derivatives
03/15/1989EP0307176A2 Erythromycin derivatives
03/15/1989EP0306863A2 Cephem compounds and processes for preparation thereof
03/15/1989EP0306860A2 4-Oxo-3-Quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
03/15/1989EP0306845A2 Medicinal preparation containing certain derivatives of 6-mercaptopurine, use of these derivatives of 6-mercaptopurine, process for the preparation of the medicinal preparation and some derivatives of 6-mercaptopurine and process for their preparation
03/15/1989EP0306844A2 Use of 6-mercaptopurines in the preparation of a pharmaceutical composition, and method for preparing this composition
03/15/1989EP0306764A2 4-Quinolone-3-carboxylic-acid derivatives and their use as antibacterial agents
03/15/1989EP0306645A2 Teicoplanin-like derivatives
03/15/1989CN1031651A Diagnosis and treatment of double-stranded rna deficiency states
03/14/1989US4812578 Reacting 4-alkoxy-3-pyrrolin-2-one with benzyl alcohol and catalytically hydrogenolyzing
03/14/1989US4812562 Cephalosporin derivatives
03/14/1989US4812472 Polio, aids
03/14/1989US4812470 Antibacterial monic acid derivatives
03/14/1989US4812465 Triazole derivatives for use as antimycotic agents
03/14/1989US4812312 Liposome-incorporated nystatin
03/14/1989CA1251215A1 Derivatives of 8-amino and 8-aminomethyl benzo¬ij|quinolizine
03/09/1989WO1989001976A1 Recombinant dna-derived bordetella toxin subunit analogs
03/09/1989WO1989001933A2 4-quinoline-3-carboxylic acid derivatives and their use as antibacterial agents
03/09/1989WO1989001930A1 Pharmaceutical compositions for the treatment of psoriasis
03/09/1989WO1989001776A1 Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil
03/08/1989EP0306455A1 Cyclodextrin complexes of bis-biguanido hexane compounds
03/08/1989EP0306318A1 Recombinant DNA-derived bordetella toxin subunit analogs
03/08/1989EP0306303A1 Anti-viral neoantigen antibodies and anti-idiotypic antibodies induced thereby as anti-viral agents
03/08/1989EP0306282A2 Antiviral compositions derived from marine sponge epipolasis reiswigi and their methods of use
03/08/1989EP0305967A2 Conjugates of interferon alpha with immunoglobulins
03/08/1989EP0305843A2 Antiviral agent